PNC Financial Services Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.08K | Sell |
|
|||||
|
2025
Q2 | $4.3K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $325 | Hold |
|
|||||
|
2024
Q3 | $284 | Hold |
|
|||||
|
2024
Q2 | $232 | Buy |
|
|||||
|
2024
Q1 | $13 | Sell |
|
|||||
|
2023
Q4 | $554 | Buy |
|
|||||
|
2023
Q3 | $99 | Sell |
|
|||||
|
2023
Q2 | $48.8K | Buy |
|
|||||
|
2023
Q1 | $41K | Buy |
|
|||||
|
2022
Q4 | $4.41K | Sell |
|
|||||
|
2022
Q3 | $41K | Sell |
|
|||||
|
2022
Q2 | $99K | Sell |
|
|||||
|
2022
Q1 | $184K | Sell |
|
|||||
|
2021
Q4 | $228K | Buy |
|
|||||
|
2021
Q3 | $232K | Buy |
|
|||||
|
2021
Q2 | $280K | Sell |
|
|||||
|
2021
Q1 | $423K | Sell |
|
|||||
|
2020
Q4 | $438K | Buy |
|
|||||
|
2020
Q3 | $431K | Sell |
|
|||||
|
2020
Q2 | $506K | Buy |
|
|||||
|
2020
Q1 | $272K | Buy |
|
|||||
|
2019
Q4 | $211K | Buy |
|
|||||
|
2019
Q3 | $169K | Buy |
|
|||||
|
2019
Q2 | $154K | Sell |
|
|||||
|
2019
Q1 | $1.75M | Buy |
|
|||||
|
2018
Q4 | $1.61M | Sell |
|
|||||
|
2018
Q3 | $2.23M | Sell |
|
|||||
|
2018
Q2 | $1.73M | Buy |
|
|||||
|
2018
Q1 | $149K | Buy |
|
|||||
|
2017
Q4 | $62K | Buy |
|
|||||
|
2017
Q3 | $37K | Buy |
|
|||||
|
2017
Q2 | $29K | Buy |
|
|||||
|
2017
Q1 | $23K | Sell |
|
|||||
|
2016
Q4 | $338K | Sell |
|
|||||
|
2016
Q3 | $325K | Sell |
|
|||||
|
2016
Q2 | $1.49M | Buy |
|
|||||
|
2016
Q1 | $453K | Buy |
|
|||||
|
2015
Q4 | $322K | Sell |
|
|||||
|
2015
Q3 | $483K | Sell |
|
|||||
|
2015
Q2 | $590K | Sell |
|
|||||
|
2015
Q1 | $790K | Sell |
|
|||||
|
2014
Q4 | $843K | Buy |
|
|||||
|
2014
Q3 | $558K | Buy |
|
|||||
|
2014
Q2 | $99K | Buy |
|
|||||
|
2014
Q1 | $19K | Buy |
|
|||||
|
2013
Q4 | $14K | Buy |
|